CELLINK logo — Create the future of health

CELLINK

Create the future of health

Founded 2016 Sweden Sweden 71 employees IPO Total: $15.94M Biotechnology, Life Sciences +1

General Information

Company Name CELLINK
Founded Year 2016
Location Sweden Sweden +2
Employees 71
Industries Biotechnology, Life Sciences, 3D Printing
Funding Stage IPO

Get notified when CELLINK moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CELLINK

CELLINK is a pioneering biotechnology company based in Sweden that is shaping the future of healthcare. Through its parent company, BICO, CELLINK has established itself as a global leader in bioconvergence, enabling breakthroughs in the field of 3D bioprinting. The company democratized access to advanced research tools by introducing the first universal bioink in 2016, a move that catalyzed the exponential growth of the 3D bioprinting industry, now valued at $1 billion. By offering an extensive range of bioinks, bioprinters, software, and services, CELLINK has garnered the trust of leading researchers and top 20 pharmaceutical companies worldwide, with over 1,000 laboratories embracing its cutting-edge innovations. These groundbreaking solutions have been referenced in 700 publications, underscoring their significant impact on the scientific community. In March 2020, CELLINK secured a notable kr2.00M grant investment from Vinnova, further reinforcing its position as a trailblazer in the biotechnology landscape. As part of the BICO bioconvergence movement, CELLINK is dedicated to realizing the potential of on-demand bioprinting of human organs and tissues, thereby shaping the future of health.

Taxonomy: bioink technology, 3D printing, human organs, tissue models, medical research, oncology research, drug testing, cosmetic testing, bioprinting innovations, bioprinting technology, Gothenburg, Sweden, Palo Alto, California

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
01 Mar 2020
Grant •••••• - 01 Apr 2019
Post Ipo Equity •••••• 1
Investor
01 Oct 2018
Post Ipo Equity •••••• 1
Investor
01 Jul 2018
Grant •••••• 1 •••• •••• 01 Jun 2017

View All 7 Funding Rounds

CELLINK Alternatives & Competitors

CELLINK vs
BICO
BICO Sweden

BICO is a leading provider of life science solutions and laboratory automation that enable more effi...

733 employees
Biotechnology, Life Sciences
CELLINK vs
LabFellows
LabFellows United States

Do More Science.

Seed
4 employees
Biotechnology, Life Sciences
CELLINK vs

In Vitro Diagnostics (IVD), Point-of-Care Testing

26 employees

FAQ About CELLINK

Create the future of health
CELLINK was founded in 2016.
CELLINK is headquartered in Sweden.
CELLINK operates in the following industries: Biotechnology, Life Sciences, 3D Printing.
CELLINK has approximately 71 employees.
CELLINK has completed 7 funding rounds, raising a total of $15.94M. The latest funding stage is IPO.
Top alternatives and competitors to CELLINK include BICO, LabFellows, Micropoint Biotechnologies, Neo-Science, Opentrons Labworks Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CELLINK and BICO are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CELLINK and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy